grant

Role of HELB in the Replication Stress Response

Organization ARKANSAS CHILDREN'S HOSPITAL RES INSTLocation LITTLE ROCK, UNITED STATESPosted 11 Jul 2017Deadline 30 Jun 2027
NIHUS FederalResearch GrantFY2025ATAC sequencingATAC-seqATACseqAbscissionAgingAssay for Transposase-Accessible Chromatin using sequencingBinding SitesBiochemicalCOBRECancersCell BodyCell CycleCell Division CycleCellsCenter of Biomedical Research ExcellenceCenters of Research ExcellenceChIP SequencingChIP-seqChIPseqChildhoodChromatinCombining SiteDNADNA Helicase BDNA HelicasesDNA Replication InitiationDNA Unwinding ProteinsDNA lesionDNA replication forkDNA unwinding enzymeDataDefectDeoxyribonucleic AcidDevelopmentDiseaseDisorderDoctor of PhilosophyEXO1EXO1 exonucleaseEXO1 geneEpigeneticEpigenetic ChangeEpigenetic MechanismEpigenetic ProcessEscalante syndromeEventExcisionExonuclease 1ExtirpationFragile XFragile X SyndromeG-QuadruplexG-Quadruplexes DNAG-Quartet StructuresG-QuartetsG-TetradsG4-DNAGenesGenomeGenome StabilityGenomic DNAGenomic StabilityGenomicsGoalsHDHBHELBHELB geneHEX1HEX1 GeneHelicase, DNA, BHumanIndividualMaintenanceMalignant NeoplasmsMalignant TumorMartin-Bell SyndromeMartin-Bell-Renpenning syndromeMental RetardationModern ManMolecularPediatric ResearchPh.D.PhDPhosphorylationPopulationPost-Translational Modification Protein/Amino Acid BiochemistryPost-Translational ModificationsPost-Translational Protein ModificationPost-Translational Protein ProcessingPosttranslational ModificationsPosttranslational Protein ProcessingProcessProliferatingProtein ModificationProtein PhosphorylationProteinsR-Series Research ProjectsR01 MechanismR01 ProgramReactive SiteRecombinantsRecoveryRegulationRemovalRenpenning syndrome 2Replication InitiationResearchResearch GrantsResearch Project GrantsResearch ProjectsResearch ResourcesResourcesRoleSiteStructureSurgical RemovalTestingX-linked mental deficiency-megalotestes syndromeX-linked mental retardation with fragile X syndromeX-linked mental retardation-fragile site 1 syndromeassaultassay for transposase accessible chromatin followed by sequencingassay for transposase accessible chromatin seqassay for transposase accessible chromatin sequencingassay for transposase-accessible chromatin with sequencingautism-fragile X (AFRAX) syndromebiological adaptation to stresschromatin immunoprecipitation coupled with sequencingchromatin immunoprecipitation followed by sequencingchromatin immunoprecipitation with sequencingchromatin immunoprecipitation-seqchromatin immunoprecipitation-sequencingdevelopmentaldevelopmental diseasedevelopmental disorderepigeneticallyepigenomicsexperimentexperimental researchexperimental studyexperimentsfra(X) syndromefra(X)(28) syndromefra(X)(q27) syndromefra(X)(q27-28) syndromefragile X-mental retardation syndromefragile Xq syndromefragile site mental retardation 1gDNAgenome integritygenome scalegenome-widegenomewidegenomic integrityhExoIhelicasehomologous recombinationinsightknock-downknockdownmacro-orchidism-marker X (MOMX) syndromemacro-orchidism-marker X syndromemalignancymar(X) syndromemarker X syndromemental retardation-macroorchidism syndromeneoplasm/cancernew drug targetnew druggable targetnew pharmacotherapy targetnew therapeutic targetnew therapy targetnovel drug targetnovel druggable targetnovel pharmacotherapy targetnovel therapeutic targetnovel therapy targetnucleasepediatricpreservationprotein protein interactionproteogenomicsrad2 nuclease family member, homolog of S. cerevisiae exonuclease 1reaction; crisisrepairrepairedreplication forkreplication stressresectionsocial rolestress responsestress; reactiontherapeutic target
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Summary
Accurate and complete replication of the genome is essential for both proliferation and genomic stability.

Genomic DNA is constantly under assault from both exogenous and endogenous agents. The resulting DNA

lesions can cause stalling of the replication fork and activation of the replication stress response (RSR). This

activates a group of proteins that protect and restart the replication fork so that genomic integrity is maintained.

Incorrect repair can lead to cancer and aging, and defects in the RSR predispose individuals to develop cancer.

Our overall goal is to define the molecular mechanisms that protect the genome during replication stress. We

have discovered that DNA Helicase B (HELB) protects stalled replication forks from aberrant degradation by

nucleases and promotes replication restart. This is consistent with data showing reduced recovery from

replication stress with HELB knockdown; however, the mechanism by which HELB promotes recovery from

replication stress is unknown. In addition, we have found that HELB enhances replication through G-quadruplex

(G4) structures, suggesting that HELB may enable the replication fork to progress through difficult to replicate

sites. Since replication stalling can result in epigenetic instability, HELB may be involved in epigenetic

maintenance in addition to genomic maintenance. HELB has also been implicated in initiation of DNA replication

and regulation of end resection in homologous recombination (HR). Due to its varied roles in multiple processes,

regulation of HELB activity is likely required. Indeed, we have evidence that HELB activity is regulated by post-

translational modifications (PTMs). We hypothesize that HELB maintains genomic and epigenetic integrity by

protecting nascent DNA from degradation, aiding in replication restart, and assisting in replication through difficult

sites. We will test this hypothesis through the following Specific Aims: (1) Ascertain the role of HELB in protection

and restart of stalled DNA replication forks, (2) Determine the function of HELB in replication through difficult to

replicate regions of the genome, and (3) Delineate the role of HELB PTMs and protein-protein interactions (PPIs)

in the replication stress response.

Grant Number: 5P20GM121293-09
NIH Institute/Center: NIH

Principal Investigator: Alicia Byrd

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →